America Uses Top Weapon to Fight Flu
The U.S. Food and Drug Administration (FDA) has approved the use of the Flusiva (mFlusiva) vaccine from Moderna for adults aged 50 and older, aimed at preventing influenza. The vaccine focuses on mRNA technology and is considered an important step in the development of influenza vaccines using modern technology.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)